Gregory Scott Duncan - 17 Aug 2023 Form 4 Insider Report for Virios Therapeutics, Inc. (VIRI)

Role: CHIEF EXECUTIVE OFFICER, Director
Signature: /s/ Greg Duncan
Issuer symbol: VIRI
Transactions as of: 17 Aug 2023
Transactions value $: $31,245
Form type: 4
Filing time: 18 Aug 2023, 07:05:06 UTC
Previous filing: 18 Jan 2023
Next filing: 28 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIRI	Common Stock	Purchase	$31.2K	+25K	+77.02%	$1.25	57.5K	17 Aug 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.00 to $1.25, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. ("Virios"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the ranges set forth in this footnote to this Form 4.

Content

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.00 to $1.25, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. ("Virios"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the ranges set forth in this footnote to this Form 4.